Literature DB >> 30086872

Diagnosis and management of postnatal fetal growth restriction.

Eloïse Giabicani1, Aurélie Pham2, Frédéric Brioude3, Delphine Mitanchez4, Irène Netchine5.   

Abstract

Fetal growth restriction (FGR) can result from multiple causes, such as genetic, epigenetic, environment, hormonal regulation, or vascular troubles and their potential interaction. The physiopathology of FGR is not yet fully elucidated, but the insulin-like growth factor system is known to play a central role. Specific clinical features can lead to the identification of genetic syndromes in some patients. FGR leads to multiple global health concerns, from the perinatal period, with higher morbidity/mortality, through infancy, with neurodevelopmental, growth, and metabolic issues, to the onset of puberty and later in life, with subfertility and elevated risks of cardiovascular and kidney diseases. Adequate follow-up and therapeutics should be offered to these patients. We first review the main molecular etiologies leading to FGR and their specificities. We then highlight the main issues that FGR can raise later in life before concluding with the proposed management of these children.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  IGF system; Silver–Russell syndrome; fetal growth restriction; imprinted disorders; intra-uterine growth retardation; small for gestational age

Mesh:

Year:  2018        PMID: 30086872     DOI: 10.1016/j.beem.2018.03.013

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  9 in total

Review 1.  New Horizons in Short Children Born Small for Gestational Age.

Authors:  Irène Netchine; Manouk van der Steen; Abel López-Bermejo; Ekaterina Koledova; Mohamad Maghnie
Journal:  Front Pediatr       Date:  2021-05-13       Impact factor: 3.418

Review 2.  Exosomes-Associated DNA-New Marker in Pregnancy Complications?

Authors:  Barbora Konečná; Ľubomíra Tóthová; Gabriela Repiská
Journal:  Int J Mol Sci       Date:  2019-06-13       Impact factor: 5.923

3.  Applying Methods for Postnatal Growth Assessment in the Clinical Setting: Evaluation in a Longitudinal Cohort of Very Preterm Infants.

Authors:  Montserrat Izquierdo Renau; Victoria Aldecoa-Bilbao; Carla Balcells Esponera; Beatriz Del Rey Hurtado de Mendoza; Martin Iriondo Sanz; Isabel Iglesias-Platas
Journal:  Nutrients       Date:  2019-11-14       Impact factor: 5.717

Review 4.  Intrauterine Growth Restriction: New Insight from the Metabolomic Approach.

Authors:  Elena Priante; Giovanna Verlato; Giuseppe Giordano; Matteo Stocchero; Silvia Visentin; Veronica Mardegan; Eugenio Baraldi
Journal:  Metabolites       Date:  2019-11-06

5.  Low Maternal DLK1 Levels at 26 Weeks Is Associated With Small for Gestational Age at Birth.

Authors:  Aurelie Pham; Delphine Mitanchez; Anne Forhan; Laurence Perin; Yves Le Bouc; Frederic Brioude; Marie-Laure Sobrier; Barbara Heude; Irene Netchine
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-28       Impact factor: 5.555

6.  Associations of maternal dietary patterns during pregnancy and fetal intrauterine development.

Authors:  Rui Qin; Ye Ding; Qun Lu; Yangqian Jiang; Jiangbo Du; Ci Song; Hong Lv; Siyuan Lv; Shiyao Tao; Lei Huang; Xin Xu; Cong Liu; Tao Jiang; Zhixu Wang; Hongxia Ma; Guangfu Jin; Yankai Xia; Zhibin Hu; Feng Zhang; Yuan Lin
Journal:  Front Nutr       Date:  2022-09-15

7.  Commentary on Special Issue "Fetal Growth: What Is New in the Clinical Research?"

Authors:  Erich Cosmi; Silvia Visentin
Journal:  J Clin Med       Date:  2022-09-29       Impact factor: 4.964

Review 8.  An Overview of Vascular Dysfunction and Determinants: The Case of Children of African Ancestry.

Authors:  Edna N Matjuda; Godwill Azeh Engwa; Constance R Sewani-Rusike; Benedicta N Nkeh-Chungag
Journal:  Front Pediatr       Date:  2021-12-10       Impact factor: 3.418

9.  Screening of patients born small for gestational age with the Silver-Russell syndrome phenotype for DLK1 variants.

Authors:  Aurélie Pham; Marie-Laure Sobrier; Eloïse Giabicani; Marilyne Le Jules Fernandes; Delphine Mitanchez; Fréderic Brioude; Irène Netchine
Journal:  Eur J Hum Genet       Date:  2021-07-19       Impact factor: 4.246

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.